Nuritas Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 44
Employees
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $34.1M
Latest Deal Amount
  • Investors
  • 15

Nuritas General Information

Description

Developer of bioactive peptides intended to extract peptides from food sources. The company's peptides help to combine artificial intelligence and genomics to discover and unlock natural Bioactive Peptides with extraordinary health benefits, enabling businesses to provide new opportunities to help apply across a wide range of application areas.

Contact Information

Website
www.nuritas.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Joshua Dawson House
  • Dawson Street Dublin 2
  • Dublin D02 RY95
  • Ireland
+353 (01) 000 0000

Nuritas Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuritas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Debt - General 28-Nov-2018 $34.1M 000.00 Completed Generating Revenue
6. Early Stage VC (Series A) 21-Dec-2017 000.00 000.00 00000 Completed Generating Revenue
5. Grant 28-Jul-2016 00.000 00.000 Completed Generating Revenue
4. Seed Round 07-Dec-2016 00.000 00.000 000.00 Completed Generating Revenue
3. Seed Round 26-Oct-2015 00.000 00.000 000.00 Completed Generating Revenue
2. Accelerator/Incubator 18-Dec-2014 $138K Completed Generating Revenue
1. Seed Round 11-Apr-2014 $138K $138K Completed Generating Revenue
To view Nuritas’s complete valuation and funding history, request access »

Nuritas Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Series A 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 19,000 $0.001183 $1.18 $1.18 1x $1.18 9.04%
To view Nuritas’s complete cap table history, request access »

Nuritas Executive Team (9)

Name Title Board Seat Contact Info
Nora Khaldi Ph.D Founder, Chief Executive Officer & Board Member
Owen Quinn Chief Financial Officer
Timothy Considine JD Chief Strategy Officer
Arthur Hiller Chief Business Development Officer
You’re viewing 4 of 9 executive team members. Get the full list »

Nuritas Board Members (5)

Name Representing Role Since
George Gunn Ph.D Self Chairman 000 0000
Matthieu Vermersch VisVires New Protein Board Member 000 0000
Nick Rosa Cultivian Sandbox Ventures Board Member 000 0000
Nora Khaldi Ph.D Nuritas Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Nuritas Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nuritas Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advisors.Fund Venture Capital Minority 000 0000 000000 0
Builders VC Venture Capital Minority 000 0000 000000 0
Cultivian Sandbox Ventures Venture Capital Minority 000 0000 000000 0
David Evans Angel (individual) Minority 000 0000 000000 0
Enterprise Ireland Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »